In this roundtable, hear from two industry thought leaders who share their ideas on how to build synergy between pharma and patients.

What is it like to switch from medicine to MA, and are we about to see this spike in the wake of COVID-19?

With continued drive for equality across the pharma industry, the issue of parental leave is coming to the fore. But is the industry’s approach sufficiently transparent, and what more can be done?

How can pharma embrace post-conference momentum?

What is a digital twin and how do they benefit pharma?

How can pharma boost R&D efforts into women’s health issues?

Decentralised clinical trials are held in high regard in terms of climate impact, but are they as sustainable as they seem?

How can pharma tackle public mistrust in genomic medicine?